Apotea AB (publ)CHIX:APOTES 18 3-Year ROIIC % is 39.06 as of Dec. 2025, which is 33% above its 10-year median of 29.41. GuruFocus rates CHIX:APOTES with a GF Score™ of 18/100. The stock has 1 warning sign investors should review. Among 621 Healthcare Providers & Services companies, Apotea AB (publ) ranks better than 81.8% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Apotea AB (publ)'s 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 39.06%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Apotea AB (publ)'s 3-Year ROIIC % or its related term are showing as below:
CHIX:APOTEs's 3-Year ROIIC % is ranked better than 81.8% of 621
companies
in the Healthcare Providers & Services industry
Industry Median: 3.46
vs CHIX:APOTEs: 39.06
Apotea AB (publ) (CHIX:APOTEs) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Apotea AB (publ) 3-Year ROIIC % Related Terms
Apotea AB (publ) 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Apotea AB (publ)'s 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apotea AB (publ) 3-Year ROIIC % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Apotea AB (publ)'s 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apotea AB (publ) 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Apotea AB (publ)'s 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Apotea AB (publ)'s 3-Year ROIIC % falls into.
Apotea AB (publ)'s 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 237.15933 (Dec. 2025) - 28.9247 (Dec. 2022) )
/
( 1312.5 (Dec. 2025) - 779.4 (Dec. 2022) )
=
208.23463
/
533.1
=
39.06%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Apotea AB (publ) (CHIX:APOTES) has a 3-Year ROIIC % of 39.06 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Apotea AB (publ) and its competitors. This is 33% above median its historical median of 29.41. Over the past decade, Apotea AB (publ)'s 3-Year ROIIC % has ranged from 19.76 to 39.06. According to the industry distribution chart, Apotea AB (publ) ranks #113 out of 621 companies in the Healthcare Providers & Services industry, placing it in the top 18.2%.
Is Apotea AB (publ)'s 3-Year ROIIC % too high?
Apotea AB (publ)'s current 3-Year ROIIC % of 39.06 is 33% above median its 10-year median of 29.41. Over the past 10 years, this metric has ranged from a low of 19.76 to a high of 39.06. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.46. Apotea AB (publ)'s value of 39.06 is 1028.9% above this industry median. Based on the distribution chart, Apotea AB (publ) ranks #113 out of 621 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Apotea AB (publ) has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Apotea AB (publ)'s 3-Year ROIIC % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Apotea AB (publ) ranks #113 out of 621 companies for 3-Year ROIIC %. This places Apotea AB (publ) in the top 18% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 3.46. Apotea AB (publ)'s value of 39.06 is 1028.9% above this benchmark. Historically, Apotea AB (publ)'s own 3-Year ROIIC % has ranged from 19.76 to 39.06 over the past decade. While the company's 10-year median is 29.41 vs. the industry median of 3.46, Apotea AB (publ) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.46, based on 621 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apotea AB (publ)'s current 3-Year ROIIC % of 39.06 is 1028.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Apotea AB (publ) and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apotea AB (publ)'s current 3-Year ROIIC % is 39.06, which is 33% above median its own 10-year median of 29.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apotea AB (publ) stock overvalued right now?
Apotea AB (publ) (CHIX:APOTES) has a current 3-Year ROIIC % of 39.06. The current 3-Year ROIIC % is 39.06, which is 33% above median its 10-year median of 29.41 and 1028.9% above the Healthcare Providers & Services industry median of 3.46. Apotea AB (publ)'s overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Apotea AB (publ) (CHIX:APOTES), the current 3-Year ROIIC % is 39.06 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
18GF Score
Get the complete analysis for CHIX:APOTES
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:APOTES has been successfully added to your 
